The population pharmacokinetics of theophylline in neonates and young infants
- 1 February 1989
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 17 (1) , 47-66
- https://doi.org/10.1007/bf01059087
Abstract
The population pharmacokinetics of theophylline were evaluated using 391 theophylline serum concentration measurements from 108 neonates and young infants (postnatal age 0–26 weeks), who received theophylline for the treatment of neonatal apnea. A one-compartment pharmacokinetic model with first-order elimination was used, with intravenous aminophylline and oral theophylline administration modeled as zero-order infusions. The effect of a variety of developmental and demographic factors on clearance (CL) and volume (V) were investigated. Hypothesis testing to evaluate potentially significant factors produced a final model in which clearance was based on weight (kg) raised to an exponential power and postnatal age (weeks), with CL (ml/hr)=17.5 (weight)1.28 + 1.17 (postnatal age). Clearance was reduced by 12% for patients receiving parenteral nutrition. Volume of distribution in this population was adequately described using only weight, with V (L)=0.858 L/kg. Bioavailability of orally administered drug was not significantly less than unity. Interindividual variability in clearance was modest, with a coefficient of variation for clearance of 16%. An estimate of interindividual variability in volume could not be obtained. As a measure of residual variability in theophylline serum concentrations, the coefficients of variation for theophylline serum concentrations of 5.0, 10.0, and 13.0 mg/L were found to be approximately, 25, 12, and 9%, respectively. The identification of influential patient factors and the quantification of their influence on theophylline disposition allow for a priori estimates of theophylline pharmacokinetic parameters in these patients.This publication has 48 references indexed in Scilit:
- Methods for intravenous drug administration in the pediatric patientThe Journal of Pediatrics, 1981
- Comparative effects of antacids, enteric coating, and bile salts on the efficacy of oral pancreatic enzyme therapy in cystic fibrosisThe Journal of Pediatrics, 1981
- A simplified score for assessment of fetal maturation of newly born infantsThe Journal of Pediatrics, 1979
- Interconversion of theophylline and caffeine in newborn infantsThe Journal of Pediatrics, 1979
- Dose-dependent kinetics of theophylline disposition in asthmatic childrenThe Journal of Pediatrics, 1977
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Conjugated hyperbilirubinemia in infancy associated with parenteral alimentationThe Journal of Pediatrics, 1977
- Neonatal apnea: Pathogenesis and therapyThe Journal of Pediatrics, 1977
- Theophylline pharmacokinetics in premature infants with apneaThe Journal of Pediatrics, 1976
- Controlled clinical trial of phenobarbital and/or light in reducing neonatal hyperbilirubinemia in a predominantly Negro populationThe Journal of Pediatrics, 1971